Subcutaneous Panniculitis-Like T-Cell Lymphoma

specific

A cytotoxic primary cutaneous T-cell lymphoma. Recent studies suggest there are at least two groups of subcutaneous panniculitis-like T-cell lymphomas, each with distinct histologic features, immunophenotypic profile, and prognosis. One group has an alpha/beta, CD8 positive phenotype, involves only subcutaneous tissues, and usually has an indolent clinical course. The second group has a gamma/delta phenotype, is CD8 negative, often co-expresses CD56, is not confined to the subcutaneous tissues,

15

Centers

17

Active Trials

Cancer Funding

Top Centers for Subcutaneous Panniculitis-Like T-Cell Lymphoma(15)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.8
2
NCI Clinical
High-Volume Research Center
72.8
3
NCI Comprehensive
Active Research Program
50.3
4
NCI Comprehensive
Active Research Program
50.3
5
NCI Comprehensive
Active Research Program
50.3
6
NCI Comprehensive
Active Research Program
50.3
7
NCI Comprehensive
Active Research Program
50.3
8
NCI Comprehensive
Active Research Program
50.3
9
NCI Clinical
Active Research Program
50.3
10
NCI Comprehensive
Active Research Program
50.3
11
Active Research Program
50.3
12
Active Research Program
50.3
13
Active Research Program
50.3
14
Active Research Program
50.3
15
Active Research Program
50.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →